HealthEquity (HQY) Tops Q4 EPS by 3c

HealthEquity (NASDAQ: HQY) reported Q4 EPS of $0.42, $0.03 better than the analyst estimate of $0.39. Revenue for the quarter came in at $188.2 million versus the consensus estimate of $185.36 million.

GUIDANCE:

HealthEquity sees FY2022 EPS of $1.37-$1.42, versus the consensus of $1.70. HealthEquity sees FY2022 revenue of $750-760 million, versus the consensus of $57.42 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• Pfizer lung cancer drug misses survival goal in Phase 3 trial